TAK-021
/ Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 04, 2022
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
(PubMed, Vaccine)
- "The results show that TAK-021 can confer protection in mice against the EV71 sub-genogroups tested."
Journal • Preclinical
June 25, 2019
An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
(PubMed, Vaccine)
- "These data show that the EV71 candidate vaccine is safe and immunogenic in adults and supports further clinical development as a potential pediatric vaccine by initiating a dose-escalation study for determining the dose-dependent safety and immunogenicity of the vaccine in young naïve children."
Clinical • Journal • Pain • Pediatrics
1 to 2
Of
2
Go to page
1